Prelude Therapeutics (PRLD) Other Working Capital Changes (2019 - 2026)
Prelude Therapeutics (PRLD) reported Other Working Capital Changes of -$4.6 million for Q1 2026, down 9060.0% on a YoY basis from $51116.1 in Q1 2025, and down 330.45% sequentially from -$1.1 million in Q4 2025.
Prelude Therapeutics (PRLD) Other Working Capital Changes (2019 - 2026) Analysis & Trends
Prelude Therapeutics (PRLD) has 8 years of Other Working Capital Changes data on file, last reported at -$4.6 million in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes fell 9060.0% year-over-year to -$4.6 million; the trailing twelve-month figure through Mar 2026 stood at -$4.5 million (down 2146.36% YoY), and the FY2025 full-year result was $28000.0, up 107.51% from the prior year.
- Other Working Capital Changes slipped to -$4.6 million in Q1 2026, from -$1.1 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $1.2 million in Q3 2023 to a low of -$4.6 million in Q1 2026.
- A 5-year average of -$171588.2 and a median of $355000.0 in 2023 frame the typical range for Other Working Capital Changes.
- Across the five-year window, Other Working Capital Changes surged 1101.83% in 2025 and sank 9060.0% in 2026, its largest moves.
- Tracing PRLD's Other Working Capital Changes over 5 years: stood at $431000.0 in 2022, then plunged by 507.42% to -$1.8 million in 2023, then surged by 72.67% to -$480000.0 in 2024, then slumped by 121.67% to -$1.1 million in 2025, then sank by 330.45% to -$4.6 million in 2026.
- Business Quant data shows PRLD's Other Working Capital Changes at -$4.6 million in Q1 2026, -$1.1 million in Q4 2025, and $1.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Prelude Therapeutics | 324.30 Mn | 179.71 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.58 Mn |
| Mar 31, 2026 | -4.58 Mn |
| Mar 31, 2026 | -4.58 Mn |
| Dec 31, 2025 | -1.06 Mn |
| Dec 31, 2025 | -1.06 Mn |
| Dec 31, 2025 | -1.06 Mn |
| Sep 30, 2025 | 1.09 Mn |
| Sep 30, 2025 | 1.09 Mn |
| Sep 30, 2025 | 1.09 Mn |
| Jun 30, 2025 | 50,000.00 |
| Jun 30, 2025 | 50,000.00 |
| Jun 30, 2025 | 50,000.00 |
| Mar 31, 2025 | -50,000.00 |
| Mar 31, 2025 | -50,000.00 |
| Mar 31, 2025 | -50,000.00 |
| Dec 31, 2024 | -480,000.00 |
| Dec 31, 2024 | -480,000.00 |
| Dec 31, 2024 | -480,000.00 |
| Sep 30, 2024 | -109,000.00 |
| Sep 30, 2024 | -109,000.00 |